Psychotherapy Plus: Combining Cognitive Behavioral Therapy With tDCS
Primary Purpose
Major Depression
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
cognitive behavioral therapy
tDCS
sham-tDCS
Sponsored by
About this trial
This is an interventional treatment trial for Major Depression focused on measuring tDCS, cognitive behavioral therapy
Eligibility Criteria
Inclusion Criteria:
- unipolar major depressive disorder
Exclusion Criteria:
- neurological diseases or relevant psychiatric diseases other than major depressive disorder
- current medication other than SSRI or Mirtazapine
- manic episodes (lifetime)
- psychotic symptoms (lifetime)
- treatment with psychotherapy within the past 2 years
- treatment with electroconvulsive therapy (lifetime)
Sites / Locations
- Charité University Medicine Berlin, Department of Psychiatry and Psychotherapy
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Placebo Comparator
Arm Label
cognitive behavioral therapy + tDCS
cognitive behavioral therapy + sham-tDCS
cognitive behavioral therapy
Arm Description
Group cognitive behavioral therapy combined with tDCS
Group cognitive behavioral therapy combined with sham-tDCS
Group cognitive behavioral therapy only
Outcomes
Primary Outcome Measures
Change in depression severity as measured by Montgomery Asberg Depression Rating Scale (MADRS)
MADRS ratings by trained clinicans, comparison between MADRS at baseline to MADRS post intervention, group comparison: treatment group vs. the two control interventions.
Secondary Outcome Measures
Full Information
NCT ID
NCT02633449
First Posted
December 15, 2015
Last Updated
August 24, 2021
Sponsor
Charite University, Berlin, Germany
Collaborators
University of München, University Hospital Tuebingen, University of Freiburg, University of Leipzig, Central Institute of Mental Health, Mannheim
1. Study Identification
Unique Protocol Identification Number
NCT02633449
Brief Title
Psychotherapy Plus: Combining Cognitive Behavioral Therapy With tDCS
Official Title
Augmentation of Cognitive-Behavioral Psychotherapy With Prefrontal Direct Current Stimulation in Major Depression (Psychotherapy Plus)
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
February 2016 (undefined)
Primary Completion Date
November 15, 2019 (Actual)
Study Completion Date
January 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
Collaborators
University of München, University Hospital Tuebingen, University of Freiburg, University of Leipzig, Central Institute of Mental Health, Mannheim
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The study will investigate whether cognitive behavioral psychotherapy (CBT) combined with prefrontal transcranial direct current stimulation (tDCS) is more efficacious with regard to symptom reduction in depressed patients than CBT combined with sham-tDCS or CBT alone.
Detailed Description
Brain stimulation techniques are widely seen as promising treatment alternatives for patients not responding to or tolerating psychotropic medication. In particular, transcranial direct current stimulation (tDCS) is of special interest due to its potential to be used by a large number of patients because of its comparably ease of usage and good tolerability. Thus, a large number of studies investigating clinical effects of tDCS have been performed with statistically significant effects but that are of moderate clinical relevance. Clinical studies have mainly focused on the prefrontal cortex (PFC) as the main stimulation target based on findings of numerous studies indicating the lateral PFC to be a key dysfunctional node within brain networks involved in the pathophysiology of depression.
Studies in clinical and healthy participants indicate that tDCS is capable of positively augmenting prefrontal functions that are relevant for a successful cognitive behavioral therapy. More specifically, it has been shown that tDCS is capable of improving reappraisal strategies as well as the use of cognitive control techniques .
To date, previous studies have mainly addressed global antidepressant effects of tDCS and not effects on more circumscribed phenotypes mediated by top-down PFC processes such as impaired or biased emotional learning processes. All these trials have applied the stimulation to patients while being in a resting position. Nonetheless, recent neuropsychological studies indicate that tDCS effects appear to be "activity dependent", meaning that the stimulation effects are greater when the brain region being stimulated is simultaneously engaged in a cognitive task. Therefore, in the present study we will apply tDCS to patients with unipolar major depressive disorder during cognitive behavioral therapy (CBT), a well-established and highly effective psychotherapeutic treatment for depression.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Major Depression
Keywords
tDCS, cognitive behavioral therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
209 (Actual)
8. Arms, Groups, and Interventions
Arm Title
cognitive behavioral therapy + tDCS
Arm Type
Experimental
Arm Description
Group cognitive behavioral therapy combined with tDCS
Arm Title
cognitive behavioral therapy + sham-tDCS
Arm Type
Active Comparator
Arm Description
Group cognitive behavioral therapy combined with sham-tDCS
Arm Title
cognitive behavioral therapy
Arm Type
Placebo Comparator
Arm Description
Group cognitive behavioral therapy only
Intervention Type
Behavioral
Intervention Name(s)
cognitive behavioral therapy
Intervention Description
12 sessions of group cognitive behavioral therapy, six patients, two therapists, duration: 100 minutes, two sessions per week for a total of six weeks
Intervention Type
Device
Intervention Name(s)
tDCS
Intervention Description
transcranial direct current stimulation during cognitive behavioral therapy with delayed onset after 10 minutes for 30 minutes, 1-2 mA, anode over electrode position F3, cathode over F4
Intervention Type
Device
Intervention Name(s)
sham-tDCS
Intervention Description
sham transcranial direct current stimulation during cognitive behavioral therapy with delayed onset after 10 minutes for 30 minutes, anode over electrode position F3, cathode over F4
Primary Outcome Measure Information:
Title
Change in depression severity as measured by Montgomery Asberg Depression Rating Scale (MADRS)
Description
MADRS ratings by trained clinicans, comparison between MADRS at baseline to MADRS post intervention, group comparison: treatment group vs. the two control interventions.
Time Frame
6, 18 and 30 weeks after randomization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- unipolar major depressive disorder
Exclusion Criteria:
neurological diseases or relevant psychiatric diseases other than major depressive disorder
current medication other than SSRI or Mirtazapine
manic episodes (lifetime)
psychotic symptoms (lifetime)
treatment with psychotherapy within the past 2 years
treatment with electroconvulsive therapy (lifetime)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Malek Bajbouj, Prof. Dr.
Organizational Affiliation
Charite University, Berlin, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Charité University Medicine Berlin, Department of Psychiatry and Psychotherapy
City
Berlin
ZIP/Postal Code
12203
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
35442431
Citation
Aust S, Brakemeier EL, Spies J, Herrera-Melendez AL, Kaiser T, Fallgatter A, Plewnia C, Mayer SV, Dechantsreiter E, Burkhardt G, Strauss M, Mauche N, Normann C, Frase L, Deuschle M, Bohringer A, Padberg F, Bajbouj M. Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2022 Jun 1;79(6):528-537. doi: 10.1001/jamapsychiatry.2022.0696.
Results Reference
derived
PubMed Identifier
29214483
Citation
Bajbouj M, Aust S, Spies J, Herrera-Melendez AL, Mayer SV, Peters M, Plewnia C, Fallgatter AJ, Frase L, Normann C, Behler N, Wulf L, Brakemeier EL, Padberg F. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial. Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):797-808. doi: 10.1007/s00406-017-0859-x. Epub 2017 Dec 6.
Results Reference
derived
Learn more about this trial
Psychotherapy Plus: Combining Cognitive Behavioral Therapy With tDCS
We'll reach out to this number within 24 hrs